P

Precision Biosensor Inc
KOSDAQ:335810

Watchlist Manager
Precision Biosensor Inc
KOSDAQ:335810
Watchlist
Price: 2 655 KRW -1.48% Market Closed
Market Cap: ₩47.7B

Net Margin

-39.9%
Current
Declining
by 5.4%
vs 3-y average of -34.5%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-39.9%
=
Net Income
₩-7.9B
/
Revenue
₩19.7B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-39.9%
=
Net Income
₩-7.9B
/
Revenue
₩19.7B

Peer Comparison

Country Company Market Cap Net
Margin
KR
Precision Biosensor Inc
KOSDAQ:335810
48.4B KRW
Loading...
JP
Hoya Corp
TSE:7741
8.6T JPY
Loading...
CH
Alcon AG
SIX:ALC
30.4B CHF
Loading...
US
Medline Inc
NASDAQ:MDLN
36.7B USD
Loading...
DK
Coloplast A/S
CSE:COLO B
119.1B DKK
Loading...
US
Align Technology Inc
NASDAQ:ALGN
12B USD
Loading...
UK
ConvaTec Group PLC
LSE:CTEC
4.8B GBP
Loading...
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
42.8B CNY
Loading...
KR
HLB Inc
KOSDAQ:028300
8.7T KRW
Loading...
CA
Bausch + Lomb Corp
NYSE:BLCO
6B USD
Loading...
CH
Ypsomed Holding AG
SIX:YPSN
4.3B CHF
Loading...

Market Distribution

Lower than 89% of companies in Korea
Percentile
11th
Based on 2 632 companies
11th percentile
-39.9%
Low
-168 471.3% — -2.9%
Typical Range
-2.9% — 5.8%
High
5.8% — 21 012.5%
Distribution Statistics
Korea
Min -168 471.3%
30th Percentile -2.9%
Median 1.9%
70th Percentile 5.8%
Max 21 012.5%

Precision Biosensor Inc
Glance View

Market Cap
47.7B KRW
Industry
Health Care

Precision Biosensor, Inc. develops in-vitro diagnostics technology that provides advanced diagnostic solutions. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2020-12-22. The firm's main products include testers and cartridges. The testers are portable immunoassay diagnostic devices for on-site diagnosis that uses colorimetric and time-resolved fluorescence to check acute heart disease, metabolism, and inflammatory diseases. The cartridges are used in gold absorption and time-resolved fluorescence analysis diagnostic equipment, and can check acute heart disease, metabolism, and inflammatory diseases. The firm sells its products in domestic and overseas markets such as Europe, China, the Middle East, and Southeast Asia.

Intrinsic Value
4 190.52 KRW
Undervaluation 37%
Intrinsic Value
Price
P
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-39.9%
=
Net Income
₩-7.9B
/
Revenue
₩19.7B
What is Precision Biosensor Inc's current Net Margin?

The current Net Margin for Precision Biosensor Inc is -39.9%, which is below its 3-year median of -34.5%.

How has Net Margin changed over time?

Over the last 3 years, Precision Biosensor Inc’s Net Margin has decreased from -27.4% to -39.9%. During this period, it reached a low of -46% on Jun 30, 2025 and a high of -20.6% on Sep 30, 2023.

Back to Top